BA
54
5
VRSN
53
-4
IBM
58
-2
BMY
60
2
DD
63
3
VFC
53
5
SIG
52
3
HPQ
63
6
URBN
56
14
BWA
48
2
DVN
21
3
NWS
66
-3
MHK
49
4
MTB
67
2
GS
75
2
PLD
56
8
CSCO
67
4
SCHW
62
-2
HAS
33
3
TGT
22
2
BA
54
5
VRSN
53
-4
IBM
58
-2
BMY
60
2
DD
63
3
VFC
53
5
SIG
52
3
HPQ
63
6
URBN
56
14
BWA
48
2
DVN
21
3
NWS
66
-3
MHK
49
4
MTB
67
2
GS
75
2
PLD
56
8
CSCO
67
4
SCHW
62
-2
HAS
33
3
TGT
22
2
Financhill
Back

Rocket Pharmaceuticals Vs. Spyre Therapeutics Industry Stock Comparison

Sell
43

RCKT
Rocket Pharmaceuticals

Last Price:
14.09
Seasonality Move:
13.34%
Sell
44

SYRE
Spyre Therapeutics

Last Price:
27.68
Seasonality Move:
3.13%
Sell
43
Rocket Pharmaceuticals (RCKT) is a Sell

Is Rocket Pharmaceuticals a Buy, Sell or Hold?

  • The current Rocket Pharmaceuticals [RCKT] share price is $14.11. The Score for RCKT is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RCKT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Spyre Therapeutics (SYRE) is a Sell

Is Spyre Therapeutics a Buy, Sell or Hold?

  • The current Spyre Therapeutics [SYRE] share price is $27.70. The Score for SYRE is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • SYRE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RCKT Stock Price Chart

What is Rocket Pharmaceuticals's stock price today?

  • The Rocket Pharmaceuticals share price today is $14.11
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RCKT is experiencing buying pressure, which is a positive indicator for future bullish movement.

SYRE Stock Price Chart

What is Spyre Therapeutics's stock price today?

  • The Spyre Therapeutics share price today is $27.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SYRE is experiencing buying pressure, which is a positive indicator for future bullish movement.

RCKT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.13 Sell
Relative Strength Index (14 RSI): 37.41 Sell
Chaikin Money Flow: 1084581 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.48 - 17.76) Sell
Bollinger Bands (100): (16.17 - 21.73) Sell

SYRE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.19 Sell
Relative Strength Index (14 RSI): 36.88 Sell
Chaikin Money Flow: 402962 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (29.58 - 36.78) Sell
Bollinger Bands (100): (26.13 - 32.71) Sell

RCKT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.9 Buy
20-day SMA: 15.79 Sell
50-day SMA: 17.17 Sell
200-day SMA: 21.87 Sell
8-day EMA: 14.06 Buy
20-day EMA: 15.3 Sell
50-day EMA: 16.83 Sell
200-day EMA: 20.2 Sell

SYRE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.9 Sell
20-day SMA: 33.04 Sell
50-day SMA: 31.15 Sell
200-day SMA: 31.25 Sell
8-day EMA: 29.24 Sell
20-day EMA: 31.34 Sell
50-day EMA: 31.19 Sell
200-day EMA: 28.82 Sell

Rocket Pharmaceuticals Earnings Growth & RCKT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.13 per share, and an increase next year of $0.27 per share.

Spyre Therapeutics Earnings Growth & SYRE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $8.85 per share, and an increase next year of $0.14 per share.

Rocket Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Spyre Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):